Hemodynamic stability during labor and delivery with continuous epidural infusion

Area of Science:

• Anesthesiology
• Obstetrics
• Pharmacology

Background:

• Maternal hypotension is a common complication of epidural anesthesia used for labor pain management.
• Traditional epidural dosing often involves bolus administration, which may contribute to hemodynamic instability.
• Exploring alternative epidural administration techniques is crucial for improving maternal safety during labor.

Purpose of the Study:

• To evaluate the efficacy of continuous epidural infusion (CEI) without bolus administration in reducing the incidence of hypotension in laboring patients.
• To compare the safety and effectiveness of CEI-only versus traditional bolus epidural dosing.

Main Methods:

• A single-blind clinical study randomly assigned 50 parturients to either a CEI-only group (0.2% ropivacaine hydrochloride at 10 mL/h without bolus) or a control group (0.2% ropivacaine hydrochloride at 10 mL/h with a 10-mL bolus).
• Hypotension was defined as a 20% decrease in systolic blood pressure or mean arterial pressure (MAP), or specific blood pressure thresholds.
• Data on blood pressure, sensory block level, pain scores, and maternal/fetal vital signs were collected for 2 hours post-dosing.

Main Results:

• The incidence of hypotension was significantly lower in the CEI-only group (20%) compared to the control group (60%) (P=.009).
• Fewer patients in the CEI-only group required intervention for hypotension (20% vs. 47%).
• Sensory block onset to T10 was slower with CEI-only (54.4 minutes) versus bolus (38 minutes) (P=.04), with no differences in pain scores or vital signs.

Conclusions:

• Continuous epidural infusion of 0.2% ropivacaine hydrochloride without bolus administration effectively reduces the incidence of hypotension during labor by 67%.
• This CEI-only method appears safer than traditional bolus epidural dosing for routine labor analgesia.
• Further research is recommended to assess the safety and efficacy of this technique in high-risk obstetric patients, such as those with preeclampsia or cardiovascular disease.